Therefore, the expression level of PLC-β2 may affect the malignant potential of DCIS, that is, the low expression of PLC-β2 makes DCIS-derived cells easy to acquire invasion characteristics. This evidence concerns the gene PLCB2 and ductal breast carcinoma in situ.